Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,873 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03235934 | Glycemic Impact on Glioblastoma Outcomes | withdrawn | — | 0 | University Health Network, TorontoOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT02283944 | TMS Electrochemotherapy for Glioblastoma Multiforme | withdrawn | Phase 2 | 0 | University of AarhusOTHER | 0 | Sep 20, 2021 | clinicaltrials |
| NCT03923257 |
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Sue O'DorisioOTHER |
| 1 |
| Jun 8, 2021 |
| clinicaltrials |
| NCT03068832 | Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | May 25, 2021 | clinicaltrials |
| NCT04854044 | ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jazz PharmaceuticalsINDUSTRY | 1 | Apr 30, 2021 | clinicaltrials |
| NCT03980249 | Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells | withdrawn | Early Phase 1 | 0 | West Virginia UniversityOTHER | 1 | Apr 12, 2021 | clinicaltrials |
| NCT02532322 | Efficacy of Acetaminophen in Posterior Fossa Surgery | withdrawn | Phase 2 | 0 | Children's National Research InstituteOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT03091803 | QSM and Regional DCE MRI Permeability Using GOCART Technique | withdrawn | — | 0 | University of Southern CaliforniaOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03688568 | Study of Imatinib in Children With Neurofibromatosis and Airway Tumors | withdrawn | Phase 2 | 0 | Indiana UniversityOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT02580136 | Esthesioneuroblastoma: Outcomes After Treatment(ENB) | withdrawn | — | 0 | Ricardo L. Carrau, MDOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT03353896 | NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03880123 | Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma | withdrawn | Phase 1 | 0 | Matthew InghamOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03708913 | Neuromodulation for Hypothalamic Obesity | withdrawn | N/A | 0 | University of British ColumbiaOTHER | 1 | Nov 2, 2020 | clinicaltrials |
| NCT03177252 | Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients(Scalp block) | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT04270461 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | withdrawn | Phase 1 | 0 | Jiujiang University Affiliated HospitalOTHER_GOV | 1 | Oct 22, 2020 | clinicaltrials |
| NCT03027401 | Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | withdrawn | — | 0 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2020 | clinicaltrials |
| NCT01916187 | Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma | withdrawn | Phase 1 | 0 | NCIC Clinical Trials GroupNETWORK | 1 | Sep 21, 2020 | clinicaltrials |
| NCT02379754 | Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function | withdrawn | Phase 4 | 0 | Lund UniversityOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT02415257 | Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function | withdrawn | Phase 4 | 0 | Lund UniversityOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT03506139 | Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma | withdrawn | Phase 2 | 0 | John M. BuattiOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04106843 | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT03530605 | Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma | withdrawn | N/A | 0 | Saint Luke's Health SystemOTHER | 0 | Sep 2, 2020 | clinicaltrials |
| NCT00836628 | Study of Busulfan for Refractory Central Nervous System (CNS) Tumors | withdrawn | Phase 1 | 0 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 0 | Aug 5, 2020 | clinicaltrials |
| NCT04220892 | Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma | withdrawn | Early Phase 1 | 0 | Jose CarrilloOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT02919332 | Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma | withdrawn | — | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT03014804 | Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 24, 2020 | clinicaltrials |
| NCT00943462 | Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM | withdrawn | — | 0 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 0 | Jul 23, 2020 | clinicaltrials |
| NCT02575261 | CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients | withdrawn | Phase 1 / Phase 2 | 0 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT03252171 | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients | withdrawn | Phase 1 / Phase 2 | 0 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT04406610 | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients | withdrawn | Phase 1 / Phase 2 | 0 | Fuda Cancer Hospital, GuangzhouOTHER | 0 | Jul 16, 2020 | clinicaltrials |
| NCT03629964 | Study to Develop Head Stabilizer for Use During Brain Radiation Therapy | withdrawn | N/A | 0 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02598011 | A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care(Toca7) | withdrawn | Phase 1 | 0 | Tocagen Inc.INDUSTRY | 0 | Mar 30, 2020 | clinicaltrials |
| NCT02713984 | A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Zhi YangOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT02277561 | Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery | withdrawn | N/A | 0 | Albert Einstein College of MedicineOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03973879 | Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma | withdrawn | Phase 1 / Phase 2 | 0 | Darell BignerOTHER | 0 | Feb 11, 2020 | clinicaltrials |
| NCT02754362 | A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma | withdrawn | Phase 2 | 0 | NYU Langone HealthOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT01117155 | A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas | withdrawn | — | 0 | National Cancer Institute (NCI)NIH | 0 | Dec 12, 2019 | clinicaltrials |
| NCT04051047 | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT00984438 | Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme | withdrawn | Phase 1 / Phase 2 | 0 | University of CincinnatiOTHER | 1 | Nov 25, 2019 | clinicaltrials |
| NCT01202539 | Real-time Assessment of Frameless Intrafraction Motion | withdrawn | — | 0 | Oregon Health and Science UniversityOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT03577600 | Compassionate Treatment in Children With Brain Tumors With the Cytotron® | withdrawn | N/A | 0 | Hospital Infantil de Mexico Federico GomezOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT00977795 | A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors | withdrawn | Phase 1 / Phase 2 | 0 | Endeavor HealthOTHER | 0 | Sep 10, 2019 | clinicaltrials |
| NCT02689336 | Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Sep 9, 2019 | clinicaltrials |
| NCT03632317 | A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas | withdrawn | Phase 2 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT03480867 | Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)(PARADIGMA) | withdrawn | Phase 1 | 0 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT01212237 | Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy | withdrawn | — | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT02307604 | SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access(SPECTAbrain) | withdrawn | — | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 24, 2019 | clinicaltrials |
| NCT00645385 | Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.(Gliadel-MRS) | withdrawn | — | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 4, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Oct 25, 2021source: clinicaltrials